3SMITH D J,KING W F,BARNES L A,et al. Immunogenicity and protective immunity induced by synthetic peptides associated with putative immunodominant regions of Streptococcus mutans glucan-binding protein B[J]. Infect Immun,2003,71(3) :1179-84.
4CULSHAW S,LAROSA K,TOLANI H,et al. Immunogenie and protective potential of mutans streptococcal glueosyltransferase peptide constructs selected by major histocompafibility complex class Ⅱ allele binding[ J]. Infect Immun,2007 ,75 :915-923.
5XU Q A, YU F, FAN M W, et al. Immunogenicity and persistence of a targeted anti-caries DNA vaccine[ J]. J Dent Res ,2006,85:915.
6KLIJN N, WEERKAMP A H, DEVOS W M. Gerteticmarking of Lactococcus lactis shows its survival in the human gastrointestinaltract [ J]. Appl Environ Microbiol, 1995,61 ( 7 ) :2771-2774.
7VANDENBROUCKE K, HANG W, Van HUYSSE J, et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice [ J ]. Gastroenterology, 2004:502 -513.
8SHAO J, KAUSHAL G. Normal flora: living vehicles for non-invasive protein drug delivery[J]. Int J Pharm ,2004 : 117-124.